State Street My2030 Corporate Bond ETF (MYCJ)
Live price chart, market sentiment, and community perspectives for State Street My2030 Corporate Bond ETF (NASDAQ: MYCJ).
Live price chart, market sentiment, and community perspectives for State Street My2030 Corporate Bond ETF (NASDAQ: MYCJ).
On our desk, looking at the recent Q2 2026 data, we see 16 hedge funds and large institutions holding roughly $26.7M in the State Street My2030 Corporate Bond ETF (MYCJ). Even though total fund assets hover between $37M and $46.5M, institutional ownership shifting from 67.71% down to 61.87% indicates a minor pullback in aggregate institutional weight, despite new positions being opened by 3 funds. It's a classic target maturity puzzle where holding until the December 15, 2030 liquidation date dictates the timeline.
As a risk manager reviewing MYCJ, I note the low average daily trading volume sitting around 23k shares and a portfolio turnover of 19%. This low liquidity footprint demands caution regarding execution spreads, especially during broader fixed-income sell-offs. The trailing twelve-month yield of 4.70% and a 52-week price range spanning from $24.00 to $25.32 give us a clear boundary of expected range-bound behavior under normal rate conditions.
When evaluating the creation/redemption mechanics for MYCJ, remember that individual ETF shares are not redeemable directly from the fund except in Creation Unit Aggregations. For our trading book, this means secondary market liquidity on NASDAQ at prices like $24.46 to $24.79 governs our tactical entries, keeping execution discipline tight given the modest daily volume.
Watching the market sentiment on MYCJ, retail and institutional participants appreciate its role as part of the State Street MyIncome suite for custom bond ladder construction. However, the lack of extensive Morningstar analyst coverage underscores that it is still a niche vehicle compared to massive passive iShares iBonds alternatives, leaving most of the fundamental evaluation up to individual desk research.
From a quantitative perspective, when analyzing MYCJ's active target-maturity strategy tracking the ICE 2030 Maturity US Corporate Index, you have to account for the fundamental research-driven security selection rather than pure passive indexing. The fund's YTD and 3-month returns hovering near -0.1% reflect flat recent performance, meaning alpha generation relies heavily on sector and issuer overweight decisions rather than macro beta surges.
Explore plasma cleansing, somatic organ swaps, and BCI.